Search - tctmd.com

Displaying 1 - 20 of 44

Sort: Relevancy | Date

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

News Daily News

Novel VECTOR Procedure Creates Percutaneous Aorto-Coronary Bypass

Yael L. Maxwell

January 14, 2026

TCTMD’s Top 10 Most Popular Stories for October 2025

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2025

November 03, 2025

What’s Going to Be Hot at TCT 2025

News Opinion Editor's Corner TCT 2025

What’s Going to Be Hot at TCT 2025

Michael O'Riordan

October 09, 2025

Solid, Early Surgical Results With Polymer Mitral Valve

News Conference News NY Valves 2025

Solid, Early Surgical Results With Polymer Mitral Valve

July 02, 2025

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

News Conference News ACC 2025

Evolut Low Risk Trial: TAVI Holds Up to Surgery at 5 Years

March 30, 2025

National Data Point to Soaring TAVI Rates in Patients Under 65

News Conference News NY Valves 2024

National Data Point to Soaring TAVI Rates in Patients Under 65

Michael O'Riordan

June 14, 2024

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

News Conference News

TAVI Use Rising in Young US Patients, Yet Another Analysis Shows

Yael L. Maxwell

May 06, 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

News Conference News STS 2024

Isolated vs Concomitant SAVR Offer Similar 5-Year Outcomes: PARTNER 3

Yael L. Maxwell

February 09, 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

News Conference News STS 2024

TAVI, SAVR Almost Equally Performed in California Patients Under 60

Yael L. Maxwell

February 01, 2024

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

News Conference News TCT 2023

Some Surprises in Low-Risk TAVI Follow-up: PARTNER 3 and Evolut Trials

Michael O'Riordan

October 24, 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

News Conference News EACTS 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Michael O'Riordan

October 05, 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

News Conference News ACC 2023

Self-Expanding TAVI Holds Up to Surgery Out to 3 Years in Low-Risk Patients

March 05, 2023

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

News Daily News

FDA Alert: Possible Early Deterioration of Abbott Trifecta SAVR Valves

February 27, 2023

Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL

News Daily News

Periprocedural Adverse Events and Late Mortality: More Nuance From EXCEL

Michael O'Riordan

February 15, 2023

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

News Daily News

Patient Risk, Follow-up Duration Drive SAVR, TAVI Outcomes: Meta-analysis

January 20, 2023

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

News Daily News

Aortic Valve Disease Particularly Challenging to Manage Before Age 65: Review

December 28, 2022

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

News Daily News

Left-Sided Bioprosthetic Valves Often Dysfunctional in Pregnant Women

November 21, 2022

RAPCO: Radial Artery Beats of Both RITA and Vein Grafting at 15 Years

News Conference News AHA 2022

RAPCO: Radial Artery Beats Both RITA and Vein Grafting at 15 Years

Yael L. Maxwell

November 06, 2022

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.